Por: CBS News Health December 07, 2022
Nearly 6 million Americans have taken for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with from or dying, and it may even of developing . But the government plans to stop footing the bill within months, and millions of people who are at the highest risk of severe illness and are least able to afford the drug — the uninsured and seniors — may have to pay the full price.And that means... + full article
Chicago Sun Times USA Politics December 08, 2022
Nearly six million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many infected with COVID-19 from or dying, and it might even reduce the risk of developing long COVID.But now, within months, the government plans... + más
Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN
For some COVID patients, 'Paxlovid rebound' has nothing to do with Paxlovid | Los Angeles Times
Time USA Health November 30, 2022
Months after catching COVID-19 in December 2021, Lavanya Visvabharathy was still and suffering from symptoms including headaches and intense fatigue. So Visvabharathy, a research assistant professor of neurology at the Northwestern University Feinberg School of Medicine who has... + más
Los Angeles Times USA Science November 14, 2022
This is a story about a COVID-19 medication, a nasty trick the coronavirus sometimes plays on its victims, and how the two became a pandemic couple called “Paxlovid rebound.” It's also a story about how looks can be deceiving. Americans have been quick to embrace the... + más
Paxlovid rebound more common than initially thought, doctors say | ABC News
ABC News USA Health November 10, 2022
Six months ago, Dr. Joseph Boselli said he was prescribing the antiviral drug Paxlovid to nearly everyone who turned up at his practice with COVID.Now, the internal medicine physician at Jefferson Health in Philadelphia said he's reserving it mostly for people who are... + más
The Boston Globe USA Business November 09, 2022
A Watertown biotech company has taken a small step forward in its ambitions to give Pfizer’s COVID pill Paxlovid some competition. Enanta Pharmaceuticals told the Globe it has begun an intermediate stage clinical trial of its experimental COVID therapy this week.Enanta hopes... + más
Not far from Kendall Square, Watertown emerges as a biotech hub | The Boston Globe
Watertown has been a city for decades. Now, it’s acting like one. | The Boston Globe
CNN USA Health November 07, 2022
CNN — Paxlovid, the antiviral pill that reduces the risk of hospitalization and death from Covid-19, also reduces the risk of long Covid, according to a by researchers at the US Department of Veterans Affairs. The study, posted online as a preprint on Saturday, analyzed... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
CNN USA Health October 14, 2022
CNN — Covid-19 patients with a history of cardiovascular disease are at an increased risk of developing severe illness and could benefit most from the Covid-19 treatment Paxlovid – but there’s a catch. Paxlovid can have dangerous interactions with some of the most... + más
Pfizer pledges $120M to produce oral COVID-19 treatment Paxlovid at Michigan factory | New York Daily News
Study finds Paxlovid can interact badly with some heart medications, and White House renews COVID emergency through Jan. 11 | MarketWatch
About iurex | Privacy Policy | Disclaimer |